FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 2,473,186 | $24,138,000 | 13.76% |
| Casdin Capital, LLC | 2,600,000 | $25,376,000 | 4.46% |
| Redmile Group, LLC | 6,655,962 | $64,962,000 | 2.51% |
| 683 Capital Management, LLC | 993,711 | $9,699,000 | 0.86% |
| Endurant Capital Management LP | 155,344 | $1,516,000 | 0.57% |
| EAM Investors, LLC | 279,161 | $2,725,000 | 0.45% |
| EAM Global Investors LLC | 77,889 | $760,000 | 0.39% |
| PURA VIDA INVESTMENTS, LLC | 59,600 | $582,000 | 0.34% |
| Telemetry Investments, L.L.C. | 70,200 | $685,000 | 0.26% |
| DOHENY ASSET MANAGEMENT /CA | 29,490 | $288,000 | 0.15% |